Providence Neurological Specialties West

Portland, Oregon 97225

2 studies enrolling now · 5 studies all time

What they study most

Infusion Reaction, Multiple Sclerosis, Refractory Hematologic Malignancy, Refractory Primary Central Nervous System Lymphoma, Relapsed Hematologic Malignancy, Relapsed Primary Central Nervous System Lymphoma, Relapsed/Refractory Primary Central Nervous System Lymphoma

Studies at this site

• IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) — Recruiting now
• CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL) — Recruiting now
• A Systems Approach to Understanding Disease Processes in Multiple Sclerosis — Completed
• Comparing Risk and Severity of IRRs in Patients Premedicated With Cetirizine vs. Diphenhydramine Prior to Ocrelizumab — Completed
• Efficacy of COVID-19 Vaccination in Patients With Multiple Sclerosis Treated With Immune Modulating Medication — Stopped early